| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-06 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-06 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.14 | 5e-05 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0002 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0004 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0004 |